Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pyxis Oncology (PYXS) Return on Sales (2024 - 2025)

Pyxis Oncology (PYXS) has 2 years of Return on Sales data on record, last reported at 0.02% in Q4 2025.

  • On a quarterly basis, Return on Sales rose 3.0% to 0.02% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.06%, a 1.0% decrease, with the full-year FY2025 number at 0.06%, down 1.0% from a year prior.
  • Return on Sales reached 0.02% in Q4 2025 per PYXS's latest filing, up from 0.35% in the prior quarter.
  • Over the last five years, Return on Sales for PYXS hit a ceiling of 0.0% in Q1 2024 and a floor of 0.35% in Q3 2025.